Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/10/21
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 05/10/21
Why Earnings Season Could Be Great for Axsome Therapeutics (AXSM)Zacks Investment Research • 05/07/21
Axsome Therapeutics Joins Mental Health America and other Advocacy Organizations in Raising Awareness and Providing Support for Mental Health During Mental Health MonthGlobeNewsWire • 05/07/21
Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving TodayBenzinga • 04/26/21
FDA Begins Priority Review of Axsome Therapeutics' Potential New Depression DrugThe Motley Fool • 04/26/21
Axsome Stock Jumps After Snagging Priority Review For Depression DrugInvestors Business Daily • 04/26/21
Axsome Therapeutics Stock Jumps As FDA Accepts AXS-05 Application In Major Depressive DisorderBenzinga • 04/26/21
Axsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive DisorderGlobeNewsWire • 04/26/21
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/01/21